Technology | Treatment Planning | August 15, 2017

French company achieves CE Mark for treatment planning system for modeling and computing dose distributions with double scattering beams and pencil beam scanning

DOSIsoft Releases ISOgray Proton Therapy Treatment Planning System

August 15, 2017 — DOSIsoft SA announced the official release, with CE marking, of ISOgray Treatment Planning System (TPS) release 4.3 for proton therapy with active scanning beams (pencil beam scanning). The milestone was achieved through close collaboration with Institut Curie - Protontherapy Center of Orsay (ICPO) in France.

Due to the high energy of proton beams and specific dose deposit phenomena, proton therapy planning requires particular dose computation accuracy for dealing with uncertainties, according to the dose delivery technique.

ISOgray-Proton software is now available for modeling and computing dose distributions with double scattering beams and pencil beam scanning (PBS) technologies of IBA proton radiotherapy treatment machines.

The latest development offers new features such as:

  • Single Field Uniform Dose (SFUD) optimization to deliver a uniform dose per field in a target volume; and
  • Exacor module used to carry out PBS verification plans as well as to compare the results obtained with measurements from various detectors (e.g., IBA-MatriXX).

Robust optimization algorithms based on the Pencil Beam Kernel dose calculation model are available with user-friendly interface to offer highly conformal treatments. 

In the context of a modernization project of its center begun in 2010, ICPO near Paris, France and DOSIsoft have been collaborating actively since then for new algorithm implementation and joint research activities.

“As the first center in France to implement ISOgray-Proton, ICPO confirms the promising results from the partnership. This proton therapy planning technology offers new modalities to facilitate the treatment of tumors situated near important organs and structures like cranial base tumors.” commented Ludovic De Marzi, medical physicist at ICPO.

Read the related article "Imaging Considerations for Proton Therapy Treatment Planning."
 

 

For more information: www.dosisoft.com


Related Content

News | Radiation Therapy

April 18, 2024 — Accuray Incorporated announced that as part of its commitment to advancing patient care the company has ...

Time April 18, 2024
arrow
News | Artificial Intelligence

March 28, 2024 — As artificial intelligence (AI) makes its way into cancer care – and into discussions between ...

Time March 28, 2024
arrow
News | Prostate Cancer

March 27, 2024 — A minimally invasive treatment using MRI and transurethral ultrasound instead of surgery or radiation ...

Time March 27, 2024
arrow
Videos | Radiation Oncology

In the conclusion of this 3-part video series on recent advancements in diagnostic radiology, current editorial advisory ...

Time March 19, 2024
arrow
News | Breast Imaging

March 18, 2024 — QT Imaging Holdings, Inc., a medical device company engaged in research, development, and ...

Time March 18, 2024
arrow
Feature | Radiation Oncology | By Christine Book

Appreciating the considerable advances in the clinical application of artificial intelligence (AI) within healthcare ...

Time March 06, 2024
arrow
News | FDA

March 1, 2024 — Varian, a Siemens Healthineers company, announced that it has received 510(k) clearance from the U.S ...

Time March 01, 2024
arrow
News | Breast Imaging

February 22, 2024 — The FAST-Forward randomized trial from the UK found that ultrahypofractionated whole breast ...

Time February 22, 2024
arrow
News | Radiation Oncology

February 22, 2024 — The National Institutes of Health has launched a clinical trials network to evaluate emerging ...

Time February 22, 2024
arrow
News | Radiation Oncology

February 14, 2024 — Accuray Incorporated announced that the team at Quebec’s Montérégie Integrated Cancer Center, part ...

Time February 14, 2024
arrow
Subscribe Now